Response to rebuttal: Meta-analysis of the relationship of factor V Leiden and intrauterine growth restriction – based on solid evidence?

Thromb Haemost 2005; 94(01): 231-232
DOI: 10.1055/s-0037-1614317

Letters to the Editor

Schattauer GmbH

Tracy Dudding

¹Hunter Genetics, Hunter New England Health Service, and the University of New South Wales, Australia

,

John Attia

²Centre for Clincial Epidemiology and Biostatistics, University of Newcastle, New South Wales, Australia

References
1 Lindqvist PG, Svensson PJ, Dahlbäck B. et al. Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss – a possible evolutionary selection mechanism. Thromb Haemost 1998; 79: 69-73.
2 Erhardt E, Stankovics J, Molnar D. et al. High prevalence of factor V Leiden mutation in mothers of premature neonates. Biol Neonate 2000; 78: 145-6.
3 Lindqvist PG, Svensson PJ, Marsál K. et al. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999; 81: 532-7.
4 Infante-Rivard C, Rivard GE, Yotov WV. et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002; 347: 19-25.
5 Howley HE, Walker M, Rodger M. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol 2005; 192: 694-708.